Interestingly, CUX1 mutations detected in 8% of our cohort were not identified in the previous pediatric AML studies based on whole-genome/whole-exome sequencing and were detected in only a single patient with pediatric AML by Tarlock et al using deep-sequencing.13 This evidence concerns the gene CUX1 and acute myeloid leukemia.